Epidemiological, Clinical, and Genomic Profile in Head and Neck Cancer Patients and Their Families

Biomedicines. 2022 Dec 17;10(12):3278. doi: 10.3390/biomedicines10123278.

Abstract

Inherited cancer predisposition genes are described as risk factors in head and neck cancer (HNC) families. To explore the clinical and epidemiological data and their association with a family history of cancer, we recruited 74 patients and 164 relatives affected by cancer. The germline copy number alterations were evaluated in 18 patients using array comparative genomic hybridization. Two or more first-degree relatives with HNC, tobacco-associated tumor sites (lung, esophagus, and pancreas), or other related tumors (breast, colon, kidney, bladder, cervix, stomach carcinomas, and melanoma) were reported in 74 families. Ten index patients had no exposure to any known risk factors. Family members presented tumors of 19 topographies (30 head and neck, 26 breast, 21 colon). In first-degree relatives, siblings were frequently affected by cancer (n = 58, 13 had HNC). Breast cancer (n = 21), HNC (n = 19), and uterine carcinoma (n = 15) were commonly found in first-degree relatives and HNC in second-degree relatives (n = 11). Nineteen germline genomic imbalances were detected in 13 patients; three presented gains of WRD genes. The number of HNC patients, the degree of kinship, and the tumor types detected in each relative support the role of heredity in these families. Germline alterations may potentially contribute to cancer development.

Keywords: cancer predisposition; copy number alterations; familial cancer; head and neck cancer; risk factors.

Grants and funding

This study was supported by grants from the National Institute of Science and Technology in Oncogenomics (FAPESP 2008/57887-9 and CNPq 573589/08-9). This work was conducted during a scholarship (TCC) supported by the Coordination for the Improvement of Higher Education Personnel (CAPES) and Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP 09-50262-6), Brazil.